Authors: Schroeder, MC Hamby, JM Connolly, CJC Grohar, PJ Winters, RT Barvian, MR Moore, CW Boushelle, SL Crean, SM Kraker, AJ Driscoll, DL Vincent, PW Elliott, WL Lu, GH Batley, BL Dahring, TK Major, TC Panek, RL Doherty, AM Showalter, HDH

Citation: Mc. Schroeder et al., Soluble 2-substituted aminopyrido[2,3-d]pyrimidin-7-yl ureas. Structure-activity relationships against selected tyrosine kinases and exploration of in vitro and in vivo anticancer activity, J MED CHEM, 44(12), 2001, pp. 1915-1926

Authors: Thompson, AM Connolly, CJC Hamby, JM Boushelle, S Hartl, BG Amar, AM Kraker, AJ Driscoll, DL Steinkampf, RW Patmore, SJ Vincent, PW Roberts, BJ Elliott, WL Klohs, W Leopold, WR Showalter, HDH Denny, WA

Citation: Am. Thompson et al., 3-(3,5-dimethoxyphenyl)-1,6-naphthyridine-2,7-diamines and related 2-urea derivatives are potent and selective inhibitors of the FGF receptor-1 tyrosine kinase, J MED CHEM, 43(22), 2000, pp. 4200-4211

Authors: Klohs, WD Hamby, JM

Citation: Wd. Klohs et Jm. Hamby, Antiangiogenic agents, CURR OPIN B, 10(6), 1999, pp. 544-549

Authors: Hamby, JM Showalter, HDH

Citation: Jm. Hamby et Hdh. Showalter, Small molecule inhibitors of tumor-promoted angiogenesis, including protein tyrosine kinase inhibitors, PHARM THERA, 82(2-3), 1999, pp. 169-193

Authors: Palmer, BD Smaill, JB Boyd, M Boschelli, DH Doherty, AM Hamby, JM Khatana, SS Kramer, JB Kraker, AJ Panek, RL Lu, GH Dahring, TK Winters, RT Showalter, HDH Denny, WA

Citation: Bd. Palmer et al., Structure-activity relationships for 1-phenylbenzimidazoles as selective ATP site inhibitors of the platelet-derived growth factor receptor, J MED CHEM, 41(27), 1998, pp. 5457-5465